Author/Authors :
Heo, Eunyoung Departments of Internal Medicine - Seoul Metropolitan Government-Seoul National University Boramae Medical Center - Seoul, Korea , Oh, Se Jin Departments of Thoracic and Cardiovascular Surgery - Seoul Metropolitan Government-Seoul National University Boramae Medical Center - Seoul, Korea , Lee, Hyun Woo Departments of Internal Medicine - Seoul Metropolitan Government-Seoul National University Boramae Medical Center - Seoul, Korea , Lee, Jung-Kyu Departments of Internal Medicine - Seoul Metropolitan Government-Seoul National University Boramae Medical Center - Seoul, Korea , Kim, Deog Kyeom Departments of Internal Medicine - Seoul Metropolitan Government-Seoul National University Boramae Medical Center - Seoul, Korea , Park, Sang-Won Departments of Internal Medicine - Seoul Metropolitan Government-Seoul National University Boramae Medical Center - Seoul, Korea
Abstract :
Recent studies reported that 12%–19.7% of patients with coronavirus disease-19 (COVID-19)
exhibit cardiac injuries manifesting as an ejection fraction decline and troponin I elevation
[1,2]. Cardiac injury is associated with higher mortality, the need for ICU care, and severe
COVID-19 [3]. Recently, a 63-year-old man presented to Seoul Metropolitan GovernmentSeoul National University Boramae Medical Center with severe respiratory manifestations
and fulminant myocarditis with an enlarged left ventricle and depressed left ventricular function (ejection fraction 32%). He was placed on extracorporeal membrane oxygenation (ECMO).
After treatment with intravenous immunoglobulin, steroids, and antiviral therapy, heart function recovered within 2 weeks.
Keywords :
COVID-19 , Veno-arterial , oxygenation , ECMO
